9-13 May 2012 • Barcelona, Spain - Estro-events.org

Pre re-M -Meeting eeting CCourses
ourses Scientific
cientific PProgramme
rogramme
RTT PRe-MeeTIng COuRSe • WeDneSDaY, 9 MaY 2012
THe DeLIneaTIOn OF nORMaL STRuCTuReS: PRaCTICe anD CHaLLengeS
course dIrectors:
D. Pasini (IT) and S. Rivera (FR)
course aIms:
Intensity Modulated Radiotherapy Techniques (Static or rotational IMRT-techniques) rather than uniform intensity techniques
give the ability to conform dose distributions to a variety of complex tumour sites/volumes while sparing nearby
critical normal tissue structures (OaR) as possible.
The QuanTeC reports have summarised the evidence from a wide range of studies relating to the dose tolerance of the
main OaRs. Several of the reports highlight the issue of the normal tissue delineation considering both anatomical and
functional aspects.
In order to achieve a greater level of accuracy in the definition of OaRs, there is an urgent need to improve the knowledge
of the anatomical limits of some selected structures. It is therefore important to become familiar with contouring
procedures on the different imaging modalities implemented in the treatment planning systems, without neglecting the
organ dose-volume tolerance.
This course will specifically focus on the anatomical definition of normal structures within the head and neck, thorax
and pelvic regions.
an introductory lecture will illustrate the meaning of OaR delineation within the frame of the QuanTeC report.
The following section will be organised in:
1) a first theoretical part for each site, where an expert will give an overview of the delineation of the selected organ/s
at risk in accordance with the QuanTeC recommendations,
2) It will be followed by a practical session in which the participants will have the opportunity to apply their knowledge
in practice with the support of the faculty. They will be asked to contour organs on FaLCOn, an e-learning software
tool based on the eDuCaSe platform of eSTRO which has already been used successfully during previous workshops
on target volume delineation.
In preparation for the course and to ensure maximum benefit, the participants will be asked to use the FaLCOn platform
at home to delineate selected organs at risk. The same exercise will be repeated during the course and, after the experts’
lectures, the comparison between the exercises will be discussed by the teachers using FaLCOn tools.
as an outcome of the course we would like the participants to review their clinical practice in the context of the new
recommendations of normal structure delineation and QuanTeC guidelines.
Who should attend?
This course is designed for radiation technologists involved in planning and radiation oncologists in training.
content:
• anatomical definition of selected normal structures,
• Review of dose-volume tolerance for the selected organs based on the new evidences,
• Improving the practice on contouring.
WHaT’S neW aT eSTRO 31?
ESTRO
31
2012
1. The scientific programme of eSTRO 31 will be enriched by special sessions in an ‘Interdisciplinary Track’ where relevant
topics for radiation oncologists, physicists, radiobiologists and RTTs will be addressed jointly. not sure which
sessions you could attend? To make it more convenient for you, for each session of this track, the discipline of relevance
is indicated.
2. Have a closer look at the ‘Look Inside’ (LI) sessions. The format of these sessions allows for approximately 66% of the
time for presentation of theory followed by approximately 33% of the time for illustration via practical examples.
3. Debates (D) have been designed in the Oxford example with point and counterpoint discussions followed by conclusions
in support and against of the stance taken by the debaters.
4. We continue in the tradition of Joint Sessions (JS) with other societies such as aSTRO, eau, eCCO, eFOMP, eSMO,
eSSO, eORTC, eanM and PROS.
5. need some guidance in deciding which sessions would be most beneficial for you to attend? Here are the topics
that will be addressed on the main conference days.
thursday, 10 may 2012
The small volume challenge; Cutting edge technology; Data management and networks; Targeting perspective in
Radiobiology; adaptive RT: changing the practice
FrIday, 11 may 2012
The children, young and elderly patients deal; Theragnostic and Imaging in RT; Quality assurance of new techniques
and technologies; Microenvironment
saturday, 12 may 2012
Current practice and moving controversies; Dosimetry challenges; Theragnostic and Imaging in RT; normal tissue;
Radiobiological principles for RTT practice
sunday, 13 may 2012
Current practice and moving controversies; Predictive biomarkers in RT; Dose calculation and optimization; Looking
forward; Stem cells; RTT responsibilities and involvement in research
Page 10 /// FInal announcement /// eSTRO 31 eSTRO 31 /// FInal announcement /// Page 11